Document is current
Any future updates will be listed below
-
Authors
Pardej, Sara K. https://orcid.org/0000-0003-0299-3651
Plank, Julia R. https://orcid.org/0009-0008-5929-0651
Raman, Mira M.
Green, Tamar https://orcid.org/0000-0001-5661-8297
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (T32 MH019908)
Harvey L. and Maud C. Sorensen Foundation
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23123752)
The Stephen Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine, Stanford Maternal & Child Health Research Institute
Neurofibromatosis Therapeutic Acceleration Program (NTAP) at the John Hopkins University School of Medicine
- License Information
-
More Information
Article History
Received: 14 August 2025
Accepted: 10 January 2026
First Online: 11 February 2026
Declarations
:
: The Institutional Review Board at Stanford University School of Medicine approved the study (eProtocol #57403). All procedures were in accordance with the Declaration of Helsinki.
: The authors have no conflicts of interest.
: Written informed consent was provided by legal guardians and children aged over 7 years provided complementary written assent.
: The authors declare no competing interests.
